Madrigal Pharmaceuticals($MDGL)尽管业绩强劲,股价仍下跌,或与10-Q披露的一起诉讼有关。2026年10月9日,一名前员工在伊利诺伊州北区联邦法院提起诉讼,依据《萨班斯-奥克斯利法案》举报人保护条款指控公司报复,称其在2026年1月辞职前曾就公司部分数据与报告做法提出内部关切,并寻求金钱赔偿。公司否认指控并计划积极抗辩。
This might be why $MDGL is down today despite strong earnings. h/t StreetAccount
In the 10Q:
"On October 9, 2026, a former employee filed a complaint against the Company in the United States District Court for the Northern District of Illinois, Charlton v. Madrigal Pharmaceuticals, Inc. (the “Complaint”), alleging retaliation under the whistleblower-protection provisions of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The Complaint alleges that the plaintiff raised internal concerns about certain Company data and reporting practices prior to their resignation in January 2026 and seeks monetary damages and other relief. The Company disputes the allegations in the Complaint and plans to vigorously defend itself."
来源:Adam Feuerstein ✡️ · x.com